Susan Collins actually said...

How should Congress ensure that we are recognizing innovative science versus rewarding an innovative legal strategy that is simply designed ...

I led a bipartisan investigation with then-Senator Claire McCaskill of Missouri on sudden price spikes of off-patent drugs.

I think we're in the early innings of what will become an evolving set of tools that many innovator drug companies may engage with to protec...

Later this spring, along with my colleague Senator Tim Kaine, I will reintroduce the Biologic Patent Transparency Act to prevent drug manufa...